Executive Board
The Berlin Institute of Health is led by an Executive Board, responsible for strategic planning and implementation of the research program. The Board consists of five members: the CEO, the CFO, the Chairman of the Board of Directors of the Charité, the Dean of the Medical Faculty of the Charité and the Scientific Director of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association.
Since October 2020 Professor Christopher Baum has been the new Chief Executive Officer of BIH, replacing Professor Axel Radlach Pries after two years. More information about Professor Baum can be found in his curriculum vitae.
